Viatris Inc., a global healthcare company, announced on December 16 that it is broadening its partnership with Medochemie, a Cyprus-based pharma company, to manufacture its innovative products in Vietnam and improve patient access to high-quality locally manufactured medicines.
Under this partnership, Viatris will transfer technology that will license Medochemie to manufacture Viatris’ identified NCD products in its Vietnam facilities.
|Vu Tuan Cuong, director of the Drug Administration of Vietnam (2nd, right), and Virginia Foote, vice president of AmCham Hanoi (1st, left) at the MoU signing ceremony |
The partnership with Medochemie is intended to further fuel efforts to support the Vietnamese government’s goal to enable technology transfer, strengthen local manufacturing capabilities, and help achieve the vision of making Vietnam the ASEAN hub for pharmaceutical manufacturing in the next 10-20 years.
Yun Ju Eunice Jo, country manager of Viatris Vietnam commented, "Our relentless pursuit is to improve access to high-quality, trusted medicines and empower people worldwide to live healthier at every stage of live. Our partnership with Medochemie is yet another milestone in our localisation efforts and our commitment to further expand access to quality medicines for people in Vietnam. We will continue to work and support the government’s vision to foster access to top-quality medicines through local manufacturing.”
Daphne Pittas, board member and COO of Medochemie Ltd., noted that the partnership provides motivation to build the local pharmaceutical industry’s capabilities in manufacturing high-quality medicines such as complex solid dosage forms and injectable lifesaving antibiotics.
She added, "Medochemie strongly believes in and will continue to support the scientific and technological advancement of the pharmaceutical sector in Vietnam. It has been an active member in the country’s industrial network and is seeking to develop valued collaborations, such as this one."
As part of this partnership, Viatris and Medochemie will support the government’s vision for the localisation and manufacture of high-quality medicines in Vietnam.
| ||Viatris Vietnam launches new office in Hanoi |
Viatris Vietnam Co., Ltd. has celebrated its first anniversary and marked the expansion of its commercial footprint by opening a new office in Hanoi.
| ||Domestic pharmaceutical firms encouraged to produce rare medicines: official |
The Ministry of Health (MoH) will propose to the Government to issue policies aimed at encouraging domestic pharmaceutical enterprises to produce rare medicines in order to ensure domestic supply, said Deputy Minister of Health Nguyen Thi Lien Huong said at the Government’s regular press conference on October 29.
| ||Pharma groups step up competition |
More international pharma and medical device businesses are rushing to venture further in Vietnam, anticipating wide growth potential.
By Thuy Ngan